Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P18
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -55.33% |
| Q3 2025 | -80.39% |
| Q2 2025 | -78.10% |
| Q1 2025 | 199.37% |
| Q4 2024 | -20.34% |
| Q3 2024 | 35.71% |
| Q2 2024 | -5.36% |
| Q1 2024 | 2223.44% |
| Q4 2023 | 328.93% |
| Q3 2023 | 75.39% |
| Q2 2023 | -291.88% |
| Q1 2023 | 101.69% |
| Q4 2022 | -1439.99% |
| Q3 2022 | -91.36% |
| Q2 2022 | 605.21% |
| Q1 2022 | 110.22% |
| Q4 2021 | -1433.07% |
| Q3 2021 | 108.31% |
| Q2 2021 | -6.77% |
| Q1 2021 | -2287.81% |
| Q4 2020 | 95.77% |
| Q3 2020 | 2.73% |
| Q2 2020 | -6.77% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |